{
    "root": "1b3dbe65-328a-450b-bc3d-0b46d9acd832",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Fexinidazole",
    "value": "20250502",
    "ingredients": [
        {
            "name": "FEXINIDAZOLE",
            "code": "306ERL82IR",
            "drugbank_id": "https://go.drugbank.com/drugs/DB12265"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        }
    ],
    "indications": {
        "text": "fexinidazole tablets indicated treatment first-stage ( hemolymphatic ) second-stage ( meningoencephalitic ) human african trypanosomiasis ( hat ) due trypanosoma brucei gambiense patients 6 years age older weighing least 20 kg .",
        "doid_entities": [
            {
                "text": "african trypanosomiasis (DOID:10112)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10112"
            },
            {
                "text": "trypanosomiasis (DOID:10113)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10113"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "administer fexinidazole tablets daily food day time day . break crush tablets . ( 2.1 , 2.2 ) recommended fexinidazole tablets patients 6 years age older weighing least 20 kg ( 2.2 ) body weight type dose daily dose number tablets duration treatment greater equal 35 kg loading dose 1,800 mg 3 4 days maintenance dose 1,200 mg 2 6 days greater equal 20 kg less 35 kg loading dose 1,200 mg 2 4 days maintenance dose 600 mg 1 6 days",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "fexinidazole 600 mg tablets pale-yellow , round , biconvex tablets debossed `` 4512 `` one side . fexinidazole 600 mg tablets supplied : ndc 0024-4512-24 , child-resistant blister pack 24 tablets ( 10-day dose pack ) adults pediatric patients weighing 35 kg . ndc 0024-4512-14 , child-resistant blister pack 14 tablets ( 10-day dose pack ) pediatric patients older 6 years weighing 20 kg less 35 kg .",
    "adverseReactions": "fexinidazole tablets contraindicated : patients known hypersensitivity fexinidazole tablets and/or nitroimidazole-class drugs ( e.g . , metronidazole , tinidazole ) . patients severe hepatic impairment [ ( 5.5 ) , ( 6.1 ) , ( 8.7 ) ] . patients cockayne syndrome . severe irreversible hepatotoxicity/acute liver failure fatal outcomes reported initiation metronidazole , another nitroimidazole , structurally related fexinidazole , patients cockayne syndrome [ ( 6.2 ) ] .",
    "indications_original": "Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in patients 6 years of age and older and weighing at least 20 kg.",
    "contraindications_original": "Administer Fexinidazole Tablets once daily with food each day at about the same time of the day. Do not break or crush tablets. ( 2.1 , 2.2 ) Recommended Dosage of Fexinidazole Tablets in Patients 6 years of age and older and weighing at least 20 kg ( 2.2 ) Body Weight Type of Dose Daily Dose Number of Tablets Duration of Treatment Greater than or equal to 35 kg Loading dose 1,800 mg 3 4 days Maintenance dose 1,200 mg 2 6 days Greater than or equal to 20 kg to less than 35 kg Loading dose 1,200 mg 2 4 days Maintenance dose 600 mg 1 6 days",
    "warningsAndPrecautions_original": "Fexinidazole 600 mg tablets are pale-yellow, round, biconvex tablets debossed with \"4512\" on one side.\n                  Fexinidazole 600 mg tablets are supplied as:\n                  \n                     NDC 0024-4512-24, child-resistant blister pack of 24 tablets (10-day dose pack) for adults and pediatric patients weighing 35 kg or more.\n                     NDC 0024-4512-14, child-resistant blister pack of 14 tablets (10-day dose pack) for pediatric patients older than 6 years weighing 20 kg to less than 35 kg.",
    "adverseReactions_original": "Fexinidazole Tablets are contraindicated in:\n                  \n                     Patients with known hypersensitivity to Fexinidazole Tablets and/or any nitroimidazole-class drugs (e.g., metronidazole, tinidazole).\n                     Patients with severe hepatic impairment [see Warnings and Precautions (5.5), Adverse Reactions (6.1), and Use in Specific Populations (8.7)].\n                     \n                        Patients with Cockayne syndrome. Severe irreversible hepatotoxicity/acute liver failure with fatal outcomes have been reported after initiation of metronidazole, another nitroimidazole drug, structurally related to fexinidazole, in patients with Cockayne syndrome [see Adverse Reactions (6.2)].",
    "drug": [
        {
            "name": "Fexinidazole",
            "drugbank_id": "https://go.drugbank.com/drugs/DB12265"
        }
    ]
}